These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 10902281)

  • 21. Hepatotoxicity with flutamide.
    Karaahmet F; Kurt K
    Fertil Steril; 2012 Nov; 98(5):e27; author reply e28. PubMed ID: 22985946
    [No Abstract]   [Full Text] [Related]  

  • 22. [Treatment of hirsutism].
    Koning RP
    Ned Tijdschr Geneeskd; 1994 May; 138(21):1093-4. PubMed ID: 8202187
    [No Abstract]   [Full Text] [Related]  

  • 23. Spontaneous reporting of hepatotoxicity associated with antiandrogens: data from the Spanish pharmacovigilance system.
    Manso G; Thole Z; Salgueiro E; Revuelta P; Hidalgo A
    Pharmacoepidemiol Drug Saf; 2006 Apr; 15(4):253-9. PubMed ID: 16294367
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hepatoxicity caused by flutamide increased by hypotensive situation?].
    Serrano Hernández N; García López F; Fedriani Gorria J
    An Med Interna; 1996 Nov; 13(11):552-4. PubMed ID: 9019217
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Flutamide-associated liver toxicity during treatment with total androgen suppression and radiation therapy for prostate cancer.
    Rosenthal SA; Linstadt DE; Leibenhaut MH; Andras EJ; Brooks CP; Stickney DR; Chang GC; Wolkov HB; Gilbert RM
    Radiology; 1996 May; 199(2):451-5. PubMed ID: 8668793
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term safety and tolerability of flutamide for the treatment of hirsutism.
    Castelo-Branco C; Moyano D; Gómez O; Balasch J
    Fertil Steril; 2009 Apr; 91(4):1183-8. PubMed ID: 18339379
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of hirsutism with lowest-dose flutamide (62.5 mg/day).
    Müderris II; Bayram F; Güven M
    Gynecol Endocrinol; 2000 Feb; 14(1):38-41. PubMed ID: 10813105
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term efficacy and tolerability of flutamide combined with oral contraception in moderate to severe hirsutism: a 12-month, double-blind, parallel clinical trial.
    Calaf J; López E; Millet A; Alcañiz J; Fortuny A; Vidal O; Callejo J; Escobar-Jiménez F; Torres E; Espinós JJ;
    J Clin Endocrinol Metab; 2007 Sep; 92(9):3446-52. PubMed ID: 17566093
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Severe toxic hepatitis during flutamide (Eulexin) treatment].
    Møller S; Iversen P
    Ugeskr Laeger; 1989 Jan; 151(3):173-4. PubMed ID: 2911917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low-dose flutamide (125 mg/day) as maintenance therapy in the treatment of hirsutism.
    Venturoli S; Paradisi R; Bagnoli A; Colombo FM; Ravaioli B; Vianello F; Mancini F; Gualerzi B; Porcu E; Seracchioli R
    Horm Res; 2001; 56(1-2):25-31. PubMed ID: 11815724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Risk factor of liver disorders caused by flutamide--statistical analysis using multivariate logistic regression analysis].
    Wada T; Ueda M; Abe K; Kobari T; Yamazaki H; Nakata J; Ikemoto I; Ohishi Y; Aizawa Y
    Hinyokika Kiyo; 1999 Aug; 45(8):521-6. PubMed ID: 10500955
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A case of acute hepatitis caused by flutamide].
    Coppéré H; Perraud Y; Gérard F; Jouffre C; David A; Barthélémy C; Audigier JC
    Gastroenterol Clin Biol; 1990; 14(1):105-6. PubMed ID: 2311846
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment of hirsutism, hyperandrogenism, oligomenorrhea, dyslipidemia, and hyperinsulinism in nonobese, adolescent girls: effect of flutamide.
    Ibáñez L; Potau N; Marcos MV; de Zegher F
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3251-5. PubMed ID: 10999817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Flutamide-induced hepatotoxicity: ethical and scientific issues.
    Giorgetti R; di Muzio M; Giorgetti A; Girolami D; Borgia L; Tagliabracci A
    Eur Rev Med Pharmacol Sci; 2017 Mar; 21(1 Suppl):69-77. PubMed ID: 28379593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Therapeutic options for drug induced liver injury: the efficacy of UDCA based on EBM].
    Matsuzaki Y; Nishikawa K
    Nihon Shokakibyo Gakkai Zasshi; 2003 Jun; 100(6):659-66. PubMed ID: 12833859
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparison of spironolactone, flutamide, and finasteride efficacy in the treatment of hirsutism: a randomized, double blind, placebo-controlled trial.
    Moghetti P; Tosi F; Tosti A; Negri C; Misciali C; Perrone F; Caputo M; Muggeo M; Castello R
    J Clin Endocrinol Metab; 2000 Jan; 85(1):89-94. PubMed ID: 10634370
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatic failure with flutamide.
    Kackar RR; Desai HG
    Indian J Gastroenterol; 2003; 22(4):149-50. PubMed ID: 12962443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Fulminant hepatitis caused by flutamide].
    Andréjak M; Nguyen-Khac E; Decocq G; Capron JP
    Gastroenterol Clin Biol; 1996 Feb; 20(1):121-2. PubMed ID: 8734324
    [No Abstract]   [Full Text] [Related]  

  • 39. Polycystic ovarian syndrome: a second-take on flutamide.
    Zolton JR
    Fertil Steril; 2023 Jan; 119(1):127. PubMed ID: 36372099
    [No Abstract]   [Full Text] [Related]  

  • 40. Acute and fulminant hepatitis induced by flutamide: case series report and review of the literature.
    Brahm J; Brahm M; Segovia R; Latorre R; Zapata R; Poniachik J; Buckel E; Contreras L
    Ann Hepatol; 2011; 10(1):93-8. PubMed ID: 21301018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.